Enhanced Reality for Hemiparetic Arm in the Stroke Patients
NCT ID: NCT03270852
Last Updated: 2019-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
38 participants
INTERVENTIONAL
2019-06-13
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Recovery of Arm Movement in Stroke Patients
NCT02725853
Effect of Motor Imagery With Virtual Reality in Patients With Stroke
NCT04215679
Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke
NCT05728866
Efficacy of a Combined Transcranial Direct Current Stimulation and Virtual Reality Intervention
NCT03528018
Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients
NCT01034150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced reality
Patients are provided with occupational therapy and physical therapy (task-oriented OT 30 min, FES 20 min) daily for 50 minutes.
ER therapy is provided 2 times a day for 10 minutes for 2 weeks (10 days of treatment week), except for time of installation, calibration, and 3 minute breaks.
Enhanced reality
This prototype is developed by investigators for the first time so that it have no trademark or manufacturer name yet.
The patient sits facing the horizontal desk with the ER therapy device, and then raises the wrist joint to the fixed base. The hand, wrist, and distal forearm to be treated are positioned below the ER medical camera so that the wrist is visible on the screen. Fix the wrist and wrist joint using Velcro. When treating the distal forearm, detach the wrist fixing Velcro.
No Enhanced reality
Patients are provided with occupational therapy and physical therapy (task-oriented OT 30 min, FES 20 min) daily for 50 minutes.
No Enhanced reality
Identical rehabilitation without enhanced reality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced reality
This prototype is developed by investigators for the first time so that it have no trademark or manufacturer name yet.
The patient sits facing the horizontal desk with the ER therapy device, and then raises the wrist joint to the fixed base. The hand, wrist, and distal forearm to be treated are positioned below the ER medical camera so that the wrist is visible on the screen. Fix the wrist and wrist joint using Velcro. When treating the distal forearm, detach the wrist fixing Velcro.
No Enhanced reality
Identical rehabilitation without enhanced reality
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 9-hole pegboard ; ≥ 25% of contra-lateral hand
Exclusion Criteria
* NIH stroke scale question Ia-c ≥1
* Nottingham sensory scale; \<75% of contra-lateral hand
* Ashworth scale ≥3
* NIH stroke scale question IX ≥2
* Beck depression inventory ≥21
* Significant upper extremity disease causing hand or below elbow dysfunction
* Visual disturbance
* Refusal of participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ulsan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chang Ho Hwang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chang Ho Hwang, M.D., Ph.D.
Role: STUDY_DIRECTOR
Ulsan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ulsan University Hospital
Ulsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
chhwang8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.